// App-Quantinova.ai

e15658 : Overall survival (OS) in patients (pts) with advanced hepatocellular carcinoma (HCC) and elevated alpha-fetoprotein (AFP): A real-world retrospective study.

Researchers

Presenter

  • Kristin L. Hennenfent

Principal Investigators

  • Allicia C. Girvan

  • Aafia Chaudhry

  • Paolo Abada

  • Kristin Sheffield

  • Catherine K Herren

  • Aditya Raju

  • Eileen Farrelly

  • Lee Bowman

  • Pamela Landsman-Blumberg

Medical Centers

  • Xcenda, Kansas City, MO

  • Eli Lilly and Company, Indianapolis, IN

  • Eli Lilly and Company, Bridgewater, NJ

  • Xcenda, Palm Harbor, FL

Locations

  • United States

Companies

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Alanine transaminase

  • Alpha-fetoprotein

  • Aspartate aminotransferase

  • Solute Carrier Family 12 Member 2

Drug/Treatment

  • Alfa-fetoprotein

  • Sorafenib

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved